Your Location：
Home >
Browse articles >
Comparing irinotecan/cisplatin with etoposide/cisplatin in patients with ED-SCLC: A meta-analysis of efficacy and toxicity
Updated：2026-03-12
Previous|Next

    • Comparing irinotecan/cisplatin with etoposide/cisplatin in patients with ED-SCLC: A meta-analysis of efficacy and toxicity

    • Wang Bibo , Han Yiping , Zang Jiajie
    • Military Medical Research Vol. 27, Issue 4, Pages: 210-225(2012)

    Scan QR Code

  •  
  •  

  • Full Text(HTML)

  • Publication Info

  • Metrics

Sections
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

5

Views

7

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients
Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain
Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity

Related Author

No data

Related Institution

No data